In South-Eastern Europe, and Western and Central Europe, amphetamine-type stimulants (ATS) use and health harm remain mainly linked to amphetamine and are relatively low compared to other regions.Amphetamines are the third most common stimulant drugs group in Europe after cocaine and “ecstasy”.…
Cannabis use has risen over the past 20 years in South and Central America but is showing signs of stabilizationSouth and Central America account for around 30 per cent of global cannabis herb seizures quantity. Over the past 20 years, use among the general population aged 15-64 has increased –…
Cannabis use in Europe stabilizes after long-term growth.Cannabis remains the most widely used drug in Europe, with an estimated 31 million users in 2024 (10 million women and 21 million men).In the majority of countries with available data, use has stabilized in recent years following long-term…
Cocaine use continues to increase in Western and Central Europe as well as South-Eastern Europe, according to several indicators of use and harm.In 2024, demand-side and supply-side domestic market indicators showed diverging trends in Western and Central Europe, suggesting localized disruptions…
In the United States and in Canada use of cocaine declined among young people until 2024, but not among the general population. Men continue to account for higher levels of use and harms than women, with cocaine-related overdose deaths rising much more sharply for men over the past decade –…
Cocaine is the second most used drug in Europe, after cannabis. However, per capita consumption of the substance tends to be lower than in the Americas.Annual use of cocaine is relatively high in Western and Central Europe (the subregion with the third highest average prevalence in the world) and…
Over the past decade, the prevalence of cocaine use has remained relatively stable in some countries of South America while increasing in others. However, the most recent data from countries where available show signs of stabilization.A wide variety of cocaine products are used in the region,…
The “ecstasy” market remains concentrated in Europe (mainly Western and Central Europe)The use of “ecstasy” is relatively high in Western and Central Europe with nearly 4 million of people estimated to have used the substance in the past year in 2024. In contrast, the estimated number of users was…
Methamphetamine-related harms show mixed trends across North America.In Mexico, methamphetamine harms have increased in recent years, reflected in a growing number of people entering drug-related treatment for the substance – though recent data suggest possible signs of stabilization.In contrast,…
The health harms posed by the non-medical use of opioids remains high in North America, but have started to decline in late 2023 and in 2024.Opioid overdose deaths reached historical highs in the United States of America and Canada between 2021 and 2023 but have since started to decline, returning…
Opioid-related harms, measured as new people entering treatment, have declined in Europe.Although the share of people in treatment for opioid use disorders remains substantial in Europe, the number of people entering treatment for the first time has decreased.In Eastern Europe and South-Eastern…
Between 2000 and 2020, cannabis in Western and Central Europe and parts of South-Eastern Europe became more potent, more affordable and more frequently used in a number of countries, although these trends have stabilized in recent years.Despite this stabilization, the number of cannabis-related…
